UBS Adjusts Gilead Sciences (NASDAQ:GILD) Price Target to $84 From $88By legume / August 9, 2023 / Gilead Sciences, UBS UBS Adjusts Gilead Sciences (NASDAQ:GILD) Price Target to $84 From $88, Maintains Neutral Rating。